CClinicalTrials.gg
Status unknownNCT03841656Updated Feb 15, 2019

Influence of Gum Disease Treatment on Long-term Dental Implant Success

An observational study in Periodontitis, sponsored by University Hospital, Strasbourg, France. Status unknown. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2019-02-15.

Sponsored by University Hospital, Strasbourg, France · Observational

The sponsor has not verified this record recently (last verified Feb 2019), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
200
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The aim of this study is to evaluate the influence of periodontal care response on long term dental implant success. Investigator's hypothesis is that patients who do not well respond to periodontal care have more chance to develop peri-implant complications at long-term. The second purpose of this study is to evaluate the influence of other local, systemic, behavioral, and implant's related risk factors

02

Conditions studied

  • Periodontitis

Browse trials for

03

In context

Periodontitis

1,635 studies on the registry are indexed under Periodontitis; 327 are open to participants now.

This study's planned enrollment of 200 is above the median of 90 across 428 observational studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 966 studies on the registry; 342 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patient attending periodontal and implant treatment at the Department of Periodontology of the Dental Faculty at Strasbourg, France, between 2000-2015.

Inclusion criteria

Patient attending supporting periodontal therapy with at least one implant placed for more than 3 years

  • Patient with more than 12 teeth at baseline
  • Patient with demographic, periodontal, implant data recording
  • patient aged >30 years at Baseline

Exclusion criteria

Exclusion criteria:

  • Patient needed antibiotic prophylaxis
  • Uncontrolled diabetes
  • Systemic inflammatory or autoimmune diseases
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
200 participants (estimated)
Patient registry
No

Interventions

  • ProcedurePARORISKIMPLANT

    Patients attending periodontal and implant treatment at the Department of Periodontology of the Dental Faculty at Strasbourg, France, between 2000-2015.

06

What researchers measure

Primary outcomes

  1. Presence of peri-implantitis as measured by probing depth

    The implant has a probing depth more than or equal to 4 mm

    Time frame: At least 3 years after dental implant placement

  2. Presence of peri-implantitis as measured by erythema

    The implant has bleeding on probing

    Time frame: At least 3 years after dental implant placement

  3. Presence of peri-implantitis as measured by radiographic bone loss

    The implant has a radiographic bone loss when compared to previous radiographs

    Time frame: At least 3 years after dental implant placement

Secondary outcomes

  1. Implant survival

    presence of implant on arch Peri-implant mucositis: presence of bleeding on probing

    Time frame: At least 3 years after dental implant placement

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Papalou I, Vagia P, Cakir A, Tenenbaum H, Huck O, Davideau JL. Influence of Periodontitis, Implant, and Prosthesis Characteristics on the Peri-Implant Status: A Cross-Sectional Study. Int J Dent. 2022 Feb 7;2022:9984871. doi: 10.1155/2022/9984871. eCollection 2022. PubMed 35178092 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 15, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03841656
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
Feb 15, 2019
Start date
Mar 1, 2019 (estimated)
Primary completion
Mar 1, 2022 (estimated)
Completion
Mar 1, 2022 (estimated)
Last update
Feb 15, 2019

Study contacts

Olivier HUCK
Contact
olivier.huck@chru-strasbourg.fr
00333 ext. 116947

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion